Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2003
11/13/2003WO2003028667A3 Semisolid topical hormonal compositions and methods for treatment
11/13/2003WO2003026588A3 Methods and apparatus for extrusion of vesicles at high pressure
11/13/2003WO2003022360A3 Thermotherapy via targeted delivery of nanoscale magnetic particles
11/13/2003WO2003020262A3 Use of polyunsaturated fatty acids for intra-arterial injection for selectively occluding blood supplies to neoplasias
11/13/2003WO2003018134A3 Bioadhesive compositions and methods for enhanced mucosal drug absorption
11/13/2003WO2003017921A3 A method to improve complexation efficacy and produce high-energy cyclodextrin-complexes
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2003010281A3 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
11/13/2003WO2003000227A3 A method for preparation of vesicles loaded with biological material and different uses thereof
11/13/2003WO2002069198A3 Hla ligand database utilizing predictive algorithms and methods of making and using same
11/13/2003US20030212416 Hydrogel adhesives with enhanced cohesiveness, and peel force for use on hair or fiber-populated surfaces
11/13/2003US20030212148 Mixture of polyorthoester and excipients; sustained release
11/13/2003US20030212128 Crystalline particles of escitalopram oxalate having a median particle size of >40 mu m; cystallization by gradually cooling the solution of dissolved escitalopram oxalate at a controlled cooling rate; adding crystals of escitalopram oxalate and holding; isolating particles
11/13/2003US20030212114 Stable emulsion compositions
11/13/2003US20030212102 Novel solid dispersion compositions
11/13/2003US20030212099 Stabilized pharmacutical compositions comprising acid donors
11/13/2003US20030212090 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
11/13/2003US20030212046 Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
11/13/2003US20030212043 Menopause therapy; contraceptives
11/13/2003US20030212040 Immobilized cell using polyglucosamine; encapsulating drug
11/13/2003US20030211995 Therapy for drug resistance bacteria
11/13/2003US20030211981 Antidiabetic agents; vision disorders
11/13/2003US20030211979 FAP-activated anti-tumor compounds
11/13/2003US20030211974 Sustained release of drug using biocompatible polymer
11/13/2003US20030211973 Polyglutamic acid-camptothecin conjugates and methods of preparation
11/13/2003US20030211972 Systemic administration of a therapeutic preparation
11/13/2003US20030211969 Administering activated protein c; controlling blood coagulation
11/13/2003US20030211598 Administering antitumor agents to tissues having an epithelial membrane; drug delivery; gene therapy
11/13/2003US20030211592 Methods of terminal sterilization of biological products
11/13/2003US20030211583 Egs molecules that specifically downregulae bcl-xl experession
11/13/2003US20030211182 High speed heating; controlling temperature; mixing with antioxidant; cooling
11/13/2003US20030211181 Product and process for stabilizing Aloe vera gel
11/13/2003US20030211165 Anticancer agents; mixture of hydrophilic, crosslinked polymer and drugs
11/13/2003US20030211164 Method for preparing microparticles having a selected polymer molecular weight
11/13/2003US20030211162 Heating with carrier; mixtur eof fine and coarse particle sizes
11/13/2003US20030211161 Anhydrous mixture of polyalcohol and insulation gel; dysmenorrhea
11/13/2003US20030211160 Pharmaceutical compositions
11/13/2003US20030211159 Gaseous extraction of solvent
11/13/2003US20030211156 Film-coated tablet for improved upper gastrointestinal tract safety
11/13/2003US20030211155 Stabilized pharmaceutical composition
11/13/2003US20030211153 Somatotropin in biocompatible polymer matrix; aqueous solution administering by injection
11/13/2003US20030211145 Antiinflammatory agents, analgesics, antiarthritic agents; liquid filled capsulaes
11/13/2003US20030211144 Water-insoluble drug delivery system
11/13/2003US20030211143 Emulsion and micellar formulations for the delivery of biologically active substances to cells
11/13/2003US20030211140 Lipid encapsulating hydrophobic core; drugs; anesthetic
11/13/2003US20030211139 Synthetic vector for therapy
11/13/2003US20030211136 Mixture of water soluble polymer, taste masking compound and drug
11/13/2003US20030211134 Topical glycopyrrolate product
11/13/2003US20030211123 Using citric acid esters or ethers
11/13/2003US20030211122 Mucosal microparticle conjugate vaccine
11/13/2003US20030211115 Adjuvant compositions for mucosal and injection delivered vaccines
11/13/2003US20030211112 EGFR ligands and methods of use
11/13/2003US20030211097 Epidermal growth factor; antitumor, anticancer agents
11/13/2003US20030211094 High molecular weight derivatives of vitamin k-dependent polypeptides
11/13/2003US20030211079 Immobilization with polyoxyethylene glycol; adjust circulation half-life
11/13/2003US20030211078 Therapy for restenosis; antiischemic agents; antitumor agents; anticancer agents; complexing
11/13/2003US20030211072 Compositions with enhanced oral bioavailability
11/13/2003US20030211071 Containing crosslinked polymer and active material
11/13/2003US20030211035 Emulsion/aggregation polymeric microspheres for biomedical applications and methods of making same
11/13/2003CA2787384A1 Polymeric adhesive transdermal patch comprising rotigotine for treatment of restless leg syndrome
11/13/2003CA2749172A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum
11/13/2003CA2495787A1 Methods for delivering nucleic acid molecules into cells and assessment thereof
11/13/2003CA2491708A1 Non-viral gene delivery system
11/13/2003CA2487274A1 Spermine chemically linked to lipids and cell-specific targeting molecules as a transfection agent
11/13/2003CA2484965A1 Encapsulated cells to elicit immune response
11/13/2003CA2484874A1 Monocompartment osmotic controlled drug delivery system
11/13/2003CA2484624A1 Carvedilol pharmasolve solvate
11/13/2003CA2484621A1 Carvedilol formulations
11/13/2003CA2484599A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003CA2484425A1 Fusions of cytokines and tumor targeting proteins
11/13/2003CA2484345A1 Folate-targeted imaging agents
11/13/2003CA2484329A1 Warming and nonirritating anhydrous lubricant compositions
11/13/2003CA2484318A1 Warming and nonirritating lubricant antifungal gel compositions
11/13/2003CA2484312A1 Catechin multimers as therapeutic drug delivery agents
11/13/2003CA2484287A1 Pharmaceutical- or gene-carrier compositions with reduced hemagglutinating activity
11/13/2003CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003CA2483917A1 Formulations limiting spread of pulmonary infections
11/13/2003CA2483656A1 Reduced formate poly(alkylene oxide) for a controlled release dosage form of reboxetine
11/13/2003CA2483655A1 Methods and dosage forms for controlled delivery of oxycodone
11/13/2003CA2483552A1 Calicheamicin derivative-carrier conjugates
11/13/2003CA2483456A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis
11/13/2003CA2483120A1 Polymeric adhesive transdermal patch comprising rotigotine for treatment of restless leg syndrome
11/13/2003CA2482967A1 Binary or polynary targeting and uses thereof
11/13/2003CA2482411A1 Antibody fragments specific for human carncinoembryonic antigen (cea)
11/13/2003CA2462879A1 Immunoconjugates for the treatment of tumours
11/12/2003EP1360988A1 Dehydrating agent and method for dehydrating moist article using the agent and dehydrated article obtained by the method
11/12/2003EP1360963A2 Ganglioside-KLH conjugate vaccines with QS-21
11/12/2003EP1360957A1 Vitamin/mineral complex
11/12/2003EP1360311A2 Membrane penetrating peptides and uses thereof
11/12/2003EP1360307A2 Chimeric polypeptides of serum albumin and uses related thereto
11/12/2003EP1360208A1 Induvidualized anti-cancer antibodies
11/12/2003EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
11/12/2003EP1360202A2 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
11/12/2003EP1360169A2 Succinate salt of o-desmethyl-venlafaxine
11/12/2003EP1360168A2 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1359976A1 Fluid retention assembly for an iontophoretic delivery
11/12/2003EP1359947A2 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same
11/12/2003EP1359942A1 Targetted anti-tumor drug delivery systems
11/12/2003EP1359941A2 Albumin-based drug delivery system and antimicrobial peptides
1 ... 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 ... 1712